NVAX vs PSX · P/E 2.5, rev $196.2M vs P/E 17, rev $83.54B
Novavax Inc (NVAX) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
NVAX currently screens at market cap $1.09B and trailing P/E 2.5. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the NVAX and PSX stock pages for the full models.
Not investment advice.